Department of Physical Medicine and Rehabilitation, Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, 309 East Second Street, Pomona, CA 91766, USA.
PM R. 2010 Jul;2(7):612-8. doi: 10.1016/j.pmrj.2010.04.001.
To assess the safety and feasibility of studying osteopathic manipulative treatment and its potential effectiveness for patients with vertigo.
A nonrandomized pilot study.
Outpatient clinic affiliated with a teaching hospital and osteopathic medical school.
The subjects were older than 18 years of age, with the diagnosis of vertigo for longer than 3 months.
The patients were treated with osteopathic manipulative treatment (OMT).
Treatment effectiveness was measured with the use of the Dizziness Handicap Inventory (DHI), a validated symptom inventory. Intensity and duration of adverse effects after OMT were used to measure study safety.
Of the 18 patients who were recruited all 18 (100%) met the inclusion criteria and were enrolled in the study. Sixteen patients (88.9%) completed the treatment course with OMT, and data with respect to the DHI were obtained from all 16 (100%). Significant improvement (P<.001) in total and subcomponent DHI scores was observed after completion of treatment. Of the 8 patients with moderate pretest scores, 7 (87.5%) had mild post-test scores after undergoing OMT, and of the 8 patients with severe pretest scores, 4 (50%) had mild post-test scores. Of the 18 enrolled patients, 3 (16.7%) experienced an exacerbation of their vertigo, and 5 (27.8%) experienced muscle soreness after OMT. These adverse effects were mild and transient, not lasting longer than 24 hours.
This study showed that OMT is generally well tolerated in patients with vertigo. It also demonstrated that it is feasible to recruit a population of patients with vertigo who can complete a course of OMT and collect data by using the DHI. A randomized control trial that examines the efficacy of OMT in patients with vertigo is warranted, given that OMT may be a reasonable treatment for vertigo and the functional impairment associated with it.
评估对眩晕患者进行整骨治疗及其潜在疗效的安全性和可行性。
非随机试点研究。
教学医院和整骨医学学校的门诊诊所。
受试者年龄大于 18 岁,眩晕诊断时间超过 3 个月。
患者接受整骨治疗(OMT)。
使用已验证的症状量表眩晕残障量表(DHI)测量治疗效果。使用 OMT 后的不良反应强度和持续时间来衡量研究安全性。
18 例患者均符合纳入标准并全部入组(100%)。16 例(88.9%)患者完成 OMT 治疗疗程,16 例(100%)患者获得 DHI 数据。治疗结束后,总 DHI 评分和各分项 DHI 评分均显著改善(P<.001)。8 例中度预测试评分患者中,7 例(87.5%)经 OMT 治疗后轻度评分,8 例重度预测试评分患者中,4 例(50%)轻度评分。18 例入组患者中,3 例(16.7%)眩晕恶化,5 例(27.8%)OMT 后肌肉酸痛。这些不良反应轻微且短暂,不超过 24 小时。
本研究表明 OMT 通常可耐受眩晕患者,招募可完成 OMT 疗程并使用 DHI 收集数据的眩晕患者群体是可行的。鉴于 OMT 可能是眩晕及其相关功能障碍的合理治疗方法,有必要开展 OMT 治疗眩晕患者的随机对照试验。